Abstract
Although tamoxifen reduces disease progression, tamoxifen resistance occurs during the course of estrogen receptor-positive [ER+] breast cancer treatment. In the present study, we investigated the possibility that interleukin-8 (IL-8) is a prognostic marker for tamoxifen resistance and aimed to clarify the regulation of IL-8 expression in tamoxifen-resistant cells. Clinically, IL-8 expression is positively correlated with survival in luminal A type breast cancer patients, but not in luminal B type breast cancer patients. In addition, the levels of IL-8 mRNA and protein expression were significantly increased in tamoxifen-resistant (TamR) cells compared to tamoxifen-sensitive (TamS) cells. To determine the regulatory mechanism of IL-8 expression in TamR cells, we analyzed the activities of signaling molecules. Our results showed that the phosphorylation levels of MEK and Akt were markedly increased in TamR cells, but there was no change in the phosphorylation level of p38 MAPK. On the contrary, we observed that elevated IL-8 mRNA expression was suppressed by a specific MEK1/2 inhibitor, UO126, but not by the specific PI-3K inhibitor LY294002, in TamR cells, whereas, we found that overexpression of constitutively active-MEK (CA-M...Continue Reading
References
Nov 1, 1990·Endocrine Reviews·V C Jordan, C S Murphy
May 24, 2000·Cancer Immunology, Immunotherapy : CII·T S CollinsJ P Ting
Nov 9, 2000·American Journal of Respiratory and Critical Care Medicine·A YuanK T Luh
Feb 13, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·K AupperleG Firestein
Sep 7, 2001·Cytokine & Growth Factor Reviews·K Xie
Jan 16, 2003·Oncogene·Ariane FreundGwendal Lazennec
Feb 15, 2003·Endocrinology·Janice M KnowldenRobert I Nicholson
Apr 17, 2004·Clinical Biochemistry·Samar K KassimAli Khalifa
Jun 23, 2004·Oncogene·Ariane FreundGwendal Lazennec
Nov 10, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Ina H BenoyLuc Y Dirix
Dec 23, 2004·Endocrine-related Cancer·Alistair Ring, Mitch Dowsett
Sep 1, 2005·Angiogenesis·Aihua LiRakesh K Singh
May 9, 2006·The Journal of Surgical Research·Balraj SinghAnthony Lucci
Dec 13, 2006·Stem Cells·Pasquale SansoneMassimiliano Bonafé
Jan 31, 2007·Breast Cancer Research : BCR·Carine ChaveyGwendal Lazennec
May 30, 2007·Oncogene·P J MaxwellD J J Waugh
Sep 26, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·V Craig Jordan, Bert W O'Malley
Nov 5, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·David J J Waugh, Catherine Wilson
Dec 30, 2008·The Journal of Biological Chemistry·Daniel MartinJ Silvio Gutkind
Apr 30, 2009·Cytokine·Jie YangZhi Yao
Jun 6, 2009·PLoS Biology·Hasan KorkayaMax S Wicha
Jan 7, 2010·The Journal of Clinical Investigation·Christophe GinestierMax S Wicha
Jul 9, 2010·CA: a Cancer Journal for Clinicians·Ahmedin JemalElizabeth Ward
Aug 2, 2011·Lancet·C DaviesR Peto
Oct 8, 2011·Breast Cancer Research : BCR·Achim RodyManfred Kaufmann
Aug 28, 2012·Breast Cancer Research and Treatment·Zhi ShiRuo-Pan Huang
Sep 18, 2013·Breast Cancer Research : BCR·Jagdeep K SinghRobert B Clarke
Mar 4, 2014·Surgery·Hideaki SueokaJiro Fujimoto
Jul 15, 2015·Oncology Reports·Sangmin KimJeong Eon Lee